Recent Updates
Recently added Catalysts
MRM Negative Sentiment Score: 25/100

INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Unaudited Condensed Consolidated Financial Statements as of

Key Takeaway: Medirom Healthcare Technologies Inc. reported its unaudited condensed consolidated financial statements for the six months ending June 30, 2024. The company experienced a net loss of 588,375 yen, significantly higher than the loss reported for the same period in 2023. Total liabilities also rose, increasing concerns over financial health. The operating loss expanded noticeably during this period, indicating ongoing challenges in profitability.

Market Sentiment Analysis

CONCERNS & RISKS

  • Significant net loss of 588,375 yen for the first half of 2024.
  • Total liabilities increased to 6,191,354 yen compared to 6,633,228 yen in December 2023.
  • Operating loss grew to 636,674 yen versus 379,046 yen in the same period last year.

Full Press Release Details

INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited Condensed Consolidated Financial Statements as of June 30, 2024 and for the Six Months Ended June 30, 202 4 and 202 3
Condensed Consolidated Balance Sheets as of June 30, 202 4 (Unaudited) and December 31, 202 3 F-2
Condensed Consolidated Statements of L oss for the Six Months Ended June 30, 202 4 and 202 3 (Unaudited) F-3
Condensed Consolidated Statements of Shareholders' E quity (D eficit ) for the Six Months Ended June 30, 202 4 and 202 3 (Unaudited) F-4
Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 202 4 and 202 3 (Unaudited) F-5
Notes to Condensed Consolidated Financial Statements for the Six Months Ended June 30, 202 4 and 202 3 (Unaudited) F-7
MEDIROM HEALTHCARE TECHNOLOGIES INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
AS OF JUNE 30, 2024 (UNAUDITED) AND DECEMBER 31, 2023
(Yen in thousands, except share data)
June 30, December 31,
2024 2023
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents 144,648 106,347
Accounts receivable-trade, net of allowances of 15,932 and 15,925, respectively 76,733 621,867
Accounts receivable-other, net of allowances of 457 and 457 respectively 536,484 606,074
Inventories 160,207 139,982
Prepaid expenses and other current assets 188,733 284,434
Total current assets 1,106,805 1,758,704
Property and equipment, net 407,412 451,498
Goodwill 472,209 484,564
Other intangible assets, net 781,317 920,700
Investments 81,542 81,542
Long-term accounts receivable-other, net of allowances of 111,093 and 116,547, respectively 95,560 95,797
Right-of-use asset - operating lease, net 1,958,629 2,089,402
Lease and guarantee deposits 808,733 848,691
Deferred tax assets, net 101,636 101,636
Other assets 13,198 16,655
Total assets 5,827,041 6,849,189
LIABILITIES AND SHAREHOLDERS' DEFICIT
Current liabilities:
Accounts payable 124,436 137,697
Accrued expenses 1,036,247 1,261,909
Short-term borrowings 500,000 400,000
Current portion of long-term borrowings 92,716 100,415
Accrued income taxes 4,816 14,888
Current portion of contract liability 78,320 109,307
Advances received 228,112 402,742
Current portion of lease liability 741,511 763,422
Other current liabilities 494,609 370,213
Total current liabilities 3,300,767 3,560,593
Long-term borrowings - net of current portion 1,011,481 1,050,802
Deposit received 250,235 261,922
Contract liability - net of current portion 45,615 71,134
Lease liability - net of current portion 1,222,931 1,334,630
Asset retirement obligation 347,633 344,346
Other liabilities 12,692 9,801
Total liabilities 6,191,354 6,633,228
COMMITMENTS AND CONTINGENCIES (NOTE 12)
SHAREHOLDERS' (DEFICIT) EQUITY:
Common stock, no par value; 19,899,999 shares authorized; 5,030,850 shares issued and 4,938,350 shares outstanding at June 30, 2024; 4,975,000 shares issued and 4,882,500 shares outstanding at December 31, 2023 19,900 19,900
Class A common stock, no par value; 1 share authorized; 1 share issued and 1 share outstanding at June 30, 2024 and December 31, 2023 100 100
Treasury stock, at cost- 92,500 common shares at June 30, 2024 and December 31, 2023 (3,000) (3,000)
Additional paid-in capital 121,703 113,602
(Accumulated deficit) Retained earnings (501,904) 80,277
Total 'equity (deficit) attributable to shareholders of the Company (363,201) 210,879
Noncontrolling interests (1,112) 5,082
Total shareholders' (deficit) equity (364,313) 215,961
Total liabilities and shareholders' (deficit) equity 5,827,041 6,849,189
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MEDIROM HEALTHCARE TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE SIX MONTHS ENDED JUNE 30, 2024
AND 2023 (UNAUDITED)
(Yen in thousands, except share and per share data)
Six months ended June 30,
2024 2023
Revenues:
Revenue from directly-operated salons 3,015,663 2,598,467
Franchise revenue 415,923 489,593
Other revenues 43,695 62,730
Total revenues 3,475,281 3,150,790
Cost of revenues and operating expenses:
Cost of revenue from directly-operated salons 2,653,425 2,215,200
Cost of franchise revenue 156,014 269,229
Cost of other revenues 89,278 56,185
Selling, general and administrative expenses 1,213,238 989,222
Total cost of revenues and operating expenses 4,111,955 3,529,836
Operating loss (636,674) (379,046)
Other (expense) income:
Dividend income 2 2
Interest income 2 1
Interest expense (20,631) (16,859)
Gain from sales of salons 31,793 68,783
Subsidies 13,855 10,877
Other, net 26,883 (35,089)
Total other income 51,904 27,715
Loss before income tax expense (584,770) (351,331)
Income tax expense 3,605 3,735
Net loss (588,375) (355,066)
Less: Net loss attributable to noncontrolling interests (6,194)
Net loss attributable to shareholders of the Company (582,181) (355,066)
Net loss per share attributable to shareholders of the Company
Basic (118.56) (72.72)
Diluted (118.56) (72.72)
Weighted average shares outstanding
Basic 4,910,426 4,882,500
Diluted 4,910,426 4,882,500
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MEDIROM HEALTHCARE TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT)
FOR THE SIX MONTHS ENDED JUNE 30, 2024
AND 2023 (UNAUDITED)
(Yen in thousands, except share data)
Class A common
Common stock stock Treasury stock
Retained
Additional earnings Non Total
Shares Amount Shares Amount Shares Amount paid-in (accumulated controlling
capital deficit) interest
Balance, December 31, 2022 4,975,000 1,223,134 1 100 92,500 (3,000) 1,265,456 (2,545,068) (59,378)
Reduction in common stock and additional paid-in capital (1) (1,203,234) (1,265,456) 2,468,690
Net loss (355,066) (355,066)
Balance, June 30, 2023 4,975,000 19,900 1 100 92,500 (3,000) (431,444) (414,444)
Balance, December 31, 2023 4,975,000 19,900 1 100 92,500 (3,000) 113,602 80,277 5,082 215,961
Issuance of common stock from stock option exercises 55,850 8,101 8,101
Net loss (582,181) (6,194) (588,375)
Balance, June 30, 2024 5,030,850 19,900 1 100 92,500 (3,000) 121,703 (501,904) (1,112) (364,313)
(1)On March 31, 2023, upon the resolution of the stockholders, a reduction in the registered capital and additional reserved capital amount for common stock was approved in accordance with the Companies Act. As a result, the amounts were reclassified from registered capital and additional reserved capital for common stock to accumulated deficit.
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MEDIROM HEALTHCARE TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 2024
AND 2023 (UNAUDITED)
Six months ended June 30,
2024 2023
Cash flows from operating activities:
Net loss (588,375) (355,066)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization 196,102 100,849
Gains from sale of directly-owned salons (380,901) (350,813)
Bad debt (5,445) 6,735
Losses on disposal of property and equipment, net, other intangible assets, net and goodwill 4,667 2,175
Other non-cash losses - net (2,078) 47,909
Changes in operating assets and liabilities:
Accounts receivable-trade 295,113 (87,134)
Accounts receivable-other 69,590 282,116
Inventories (20,225) (79,714)
Prepaid expenses and other current assets 24,516 26,360
Lease and guarantee deposits 39,044 42,211
Accounts payable (13,261) 2,326
Accrued expenses (279,847) (382,096)
Accrued income taxes (10,072) (35,347)
Contract liability (56,506) (2,700)
Advances received (174,630) (148,792)
Other current liabilities 124,397 337,493
Deposit received (11,687) (16,073)
Other assets and other liabilities - net 3,878 (476)
Net cash used in operating activities (785,720) (610,037)
Cash flows from investing activities:
Purchases of time deposits (5,656)
Proceeds from maturities of time deposits 26,004
Acquisition of property and equipment (18,695) (56,241)
Cost additions to other intangible assets (158,032) (83,618)
Proceeds from sale of salons 917,941 315,400
Payment received on short-term loans receivable 112
Payment received on long-term accounts receivable-other 1,670
Net cash provided by investing activities 763,232 175,653
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MEDIROM HEALTHCARE TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 2024
AND 2023 (UNAUDITED)-(CONTINUED)
Six months ended June 30,
2024 2023
Cash flows from financing activities:
Proceeds from issuance of common stock 8,101
Proceeds from short-term borrowings 300,000
Repayment of short-term borrowings (200,000)
Repayment of long-term borrowings (47,312) (53,342)
Net cash provided by (used in) financing activities 60,789 (53,342)
Net increase (decrease) in cash and cash equivalents 38,301 (487,726)
Cash and cash equivalents at beginning of period 106,347 605,454
Cash and cash equivalents at end of period 144,648 117,728
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest 19,737 13,986
Income taxes 13,009 36,419
Non-cash investing and financing activities:
Right-of-use assets obtained in exchange for lease liabilities 271,225 459,137
Purchases of property and equipment included in accrued expenses 14,589 19,139
Purchases of intangible assets included in accrued expenses 25,100 13,077
Sales of salons included in accounts receivable 102,000
Reduction in common stock and additional paid-in capital 2,468,690
Refer to Note 4, "Leases" for supplemental cash flow information related to leases.
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MEDIROM HEALTHCARE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
FOR THE SIX MONTHS ENDED JUNE 30, 2024 AND 2023
1. Basis of Presentation and Summary of Significant Accounting Policies
Unaudited Condensed Consolidated Financial Statements
The condensed consolidated financial statements included herein are unaudited and have been prepared solely by the Company's management pursuant to the rules and regulations of the U.S. Securities and Exchange Commission for interim financial reporting.
Description of Business
MEDIROM Healthcare Technologies Inc. ("Parent") and its eight subsidiaries (collectively, the "Company") are one of the leading holistic health services providers in Japan. The Company is a franchisor and operator of healthcare salons across Japan and is a preferred platform partner for large consumer brands, healthcare service providers, and government entities to affect positive health outcomes. The Company primarily engages in three lines of business: Relaxation Salon Segment (retail), Luxury Beauty (retail) and Digital Preventative Healthcare Segment (healthtech). Refer to description below and Note 6 for segment information.
Relaxation Salon Segment (See Note 6 for segment information)
The Relaxation Salon Segment is the core of the Company's business, whereby the Company owns, develops, operates, or franchises and supports relaxation salons. The salon locations cover major cities throughout Japan, with strong market presence in the Tokyo metropolitan area. The Segment includes several Relaxation Salon brands including Re.Ra.Ku , and as of June 30, 2024 and December 31, 2023, it has a total of 308 and 314 salons, respectively. The following table presents total number of salons by operation type:
Number of
Relaxation Salons
As of June 30, As of December 31,
2024 2023
Directly-operated 215 217
Franchised 93 97
Total 308 314
The number of Directly-operated salons include 60 and 41 investor-owned salons as of June 30, 2024 and December 31, 2023, respectively.
Digital Preventative Healthcare Segment (See Note 6 for segment information)
The Digital Preventative Healthcare Segment mainly consists of the following operations: government-sponsored Specific Health Guidance program, utilizing our internally-developed on-demand health monitoring smartphone application, or Lav ; MOTHER Bracelet for fitness applications.
Luxury Beauty Segment (See Note 6 for segment information)
The Luxury Beauty Segment is a business line acquired in October 2021 and operates high brand beauty salons in the central areas of Tokyo.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements are presented in Japanese yen, the currency of the country in which the Company is incorporated and principally operates. The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC") for interim financial statements. Accordingly, they do not include all disclosures required by accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information.
The results of operations for interim period are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2024 or for any other future annual or interim period. The accompanying unaudited condensed consolidated financial information should be read in conjunction with the Company's annual financial statements and notes included in the Company's Annual Report on Form 20-F for the year ended December 31, 2023, which was filed with the SEC on June 18, 2024.
Recent Developments and Liquidity
In the six months ended June 30, 2024, the Company experienced negative cash flows from operations. Since 2020, the Company has had losses from operations. As of June 30, 2024, the Company had an accumulated deficit. However, the Company's adjusted EBITDA, which includes proceeds from sales of salons classified as an investing activity in the cash flow statement, was ( 404,112 thousand) and ( 207,239 thousand) during the six months ended June 30, 2024 and 2023, respectively.
In evaluating our ability to continue as a going concern, management considered the conditions and events which could raise substantial doubt about our ability to continue as a going concern for one year following the date the consolidated financial statements for the six months ended June 30, 2024 are issued. Management considered our current financial condition and liquidity sources, including current funds available, forecasted future cash flows, and our conditional and unconditional obligations due. As such, we expect that our cash and cash equivalents as of June 30, 2024 of 144,648 thousand will not be sufficient to fund our operating expenses, capital expenditure requirements, and debt service obligations for the 12 months after the issuance date of these consolidated financial statements and that we would require additional capital in the future. These conditions, among others, raise substantial doubt about the ability of the Company to continue as a going concern. Management plans to alleviate the conditions that raise substantial doubt by raising capital through the issuance of common stock including a follow-on offering for which the Company filed a F-1 registration statement on August 23, 2024 (to be amended), private placements, borrowings from banks, and the continued sales of directly-owned salons to investors. However, the Company's ability to issue equity securities or obtain debt financing on acceptable terms, or at all, will depend on, among other things, its financial performance, general economic factors, including inflation and then-current interest rates, the condition of the credit and capital markets and other events, some of which may be beyond the Company's control.
The Company reclassified certain amount of revenue ( 92,000 thousand) and cost of sales ( 23,217 thousand) into gain from sale of salons ( 68,783 thousand) in the condensed consolidated statements of operations for the six-month period ended June 30, 2023, to conform with the new accounting policy described in the notes to the annual financial statements. In addition, a reduction in the registered capital and additional reserved capital amount for common stock was approved by the Company's shareholders in accordance with the Japan's Companies Act on March 31, 2023. The amount available for the reduction in the registered capital and additional reserved capital under Japan's Companies Act is based on the amount recorded in the Company's general books of account, maintained in accordance with accounting principles generally accepted in Japan ("Japanese GAAP"). The additional paid in capital available for the reduction was 1,307 million under the Japanese GAAP on March 31, 2023. However, under U.S. GAAP, the amount available for the reduction was 1,265 million as of March 31, 2023. Therefore, the Company reclassified 1,265 million of additional paid-in capital to retained earnings to prevent a negative balance in additional paid-in capital on March 31, 2023 under U.S. GAAP.
The condensed consolidated financial statements for the six months ended June 30, 2024 include the accounts of Parent and the following subsidiaries: JOYHANDS WELLNESS Inc., Wing Inc., MEDIROM Shared Services Inc., Inc., SAWAN Co., Ltd., ZACC Kabushiki Kaisha ("ZACC"), Medirom Human Resources Inc., MEDIROM MOTHER Labs Inc., and MEDIROM Rehab Solutions Inc. All intercompany transactions have been eliminated in consolidation.
Significant Accounting Policies
The Company's significant accounting policies are described in Note 1 - Basis of Presentation and Summary of Significant Accounting Policies, to the financial statements for the year ended December 31, 2023 included in the Company's Annual Report on Form 20-F for the year ended December 31, 2023, which was filed with the SEC on June 18, 2024. There have been no material changes to the significant accounting policies during the six months ended June 30, 2024.
Recently Issued Accounting Pronouncements Not Yet Adopted
Disclosure Improvements
In October 2023, the FASB issued ASU No. 2023-06, Disclosure Improvements-Codification Amendments in Response to the SEC's Disclosure Update and Simplification Initiative. This new standard modified the disclosure and presentation requirements of a variety of codification topics by aligning them with the SEC's regulations. ASU 2023-06 will become effective for each amendment on the effective date of the SEC's corresponding disclosure rule changes. The Company does not believe this will have a material impact on its consolidated financial statements.
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures. The new standard requires enhanced disclosures about segment information and significant segment expenses. It does not change how a public entity identifies its operating segments. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The new standard should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact on its consolidated financial statements.
In December 2023, the FASB issued 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures. The new standard requires public business entities to disclose information about income taxes paid, specific categories in the rate reconciliation, and additional information for reconciling items that meet a quantitative threshold. The guidance should be applied on a prospective basis. For public business entities, ASU 2023-08 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. For all other entities, the standard is effective for annual periods beginning after December 15, 2025. The Company is currently evaluating the impact on its consolidated financial statements.
2. Goodwill and Other Intangible Assets, Net
The components of intangible assets as of June 30, 2024 and December 31, 2023 are as follows:
Thousands of Yen
As of As of
June 30, 2024 December 31, 2023
Intangible assets subject to amortization:
Software for internal use 224,659 220,343
Customer relationship 180,000 180,000
Store operating rights 559,669 637,138
Trademark 160,000 160,000
Other 750 750
Total 1,125,078 1,198,231
Accumulated amortization (344,130) (277,900)
Net carrying amount 780,948 920,331
Intangible assets not subject to amortization:
Goodwill 472,209 484,564
Telephone rights 369 369
Total 472,578 484,933
Total intangible assets 1,253,526 1,405,264
The aggregate amortization expense was 147,205 thousand and 50,305 thousand for the six months ended June 30, 2024 and 2023, respectively.
The following table shows changes in carrying amount of goodwill for the six months ended June 30, 2024 and for the year ended December 31, 2023:
Thousands of Yen
Balance at December 31, 2022 539,490
Sale of directly-owned salons, and closure of directly-owned salons (54,926)
Balance at December 31, 2023 484,564
Sale of directly-owned salons, and closure of directly-owned salons (12,355)
Balance at June 30, 2024 472,209
The Company concluded that there were no triggering events requiring an impairment assessment during the six months ended June 30, 2024. The Company continues to evaluate the impact of macroeconomic conditions.
The Company has borrowings with financial institutions. Some borrowings are secured. As of June 30, 2024 and December 31, 2023, time deposits with an aggregating book value of 6,156 thousand and 26,002, respectively, are pledged as collateral which is included in other current assets in the condensed consolidated balance sheets. Some borrowings are guaranteed by Credit Guarantee Association, a Japanese governmental affiliate agency which supplements private companies with credit. As of June 30, 2024 and December 31, 2023, the borrowings accrue interest using fixed interest rates of 0.21% - 3.30% per annum. Debt issuance costs related to these borrowings are immaterial.
On March 29, 2024, the Company reached an agreement with its lender and refinanced its 200 million yen short-term loan with a new 300 million yen short-term loan maturing on September 30, 2024 at an interest rate of 1-month TIBOR plus 1.2%.
The Company issued corporate convertible bonds in the aggregate amount of 500,000 thousand to Kufu Company Inc., a Japanese company, in December 2022, the terms of which the Company amended on November 1, 2024. The maturity date of the corporate convertible bonds changed from December 28, 2027 to December 31, 2025. The bonds are unsecured, accrue interest at a rate of 5.0% per annum, payable on June 30, 2023 and semi-annually thereafter, and will mature on December 31, 2025, unless earlier converted. At any time between the six-month anniversary date of December 28, 2022 and before the close of business on December 31, 2025, Kufu Company Inc., as the bond holder, may convert the bonds at its option, in whole or in part, into common shares. The Company granted a total of 40 share options, and one share option is attached to each bond equivalent to 12,500,000. The price per share used to calculate the number of the Company's common shares to be delivered upon the exercise of the share options shall be 755.
The carrying value of long-term borrowings as of June 30, 2024 and December 31, 2023 are as follow:
Thousands of Yen
As of As of
June 30, 2024 December 31, 2023
Short-term borrowings 500,000 400,000
Borrowings (Due through 2035 with weighted average interest rates of 0.26% as of June 30, 2024, due through 2035 with weighted average interest rates of 0.29% as of December 31, 2023) 604,197 651,217
Corporate convertible bond 500,000 500,000
Current portion of borrowings (592,716) (500,415)
Borrowings, net of current portion 1,011,481 1,050,802
The carrying value of the Company's borrowings approximate fair value at each balance sheet date because the stated rate of interest of the debt approximates the market interest rate at which the Company can borrow similar debt. As of June 30, 2024 and December 31, 2023, the Company did not have any borrowings measured at fair value.
The following is a summary of maturities of long-term borrowings subsequent to June 30, 2024:
Thousands of Yen
Year ending December 31:
2024 (remainder) 53,395
2025 86,603
2026 94,587
2027 594,627
2028 94,664
2029 and thereafter 180,321
Total 1,104,197
The Company has short-term and long-term borrowings. These borrowings are primarily made under general agreements, which are to provide security and guarantees for present and future indebtedness or to secure a guarantor upon request of the bank, and that the banks shall have the right to offset cash deposits against any debts and obligations that have become due or, in the case of default, against all obligations to the banks. Kouji Eguchi, the representative director and the shareholder of Parent (holds 38.61% of common stock and all Class A common stock as of June 30, 2024) is a guarantor for five bank loans on behalf of the Company. As of June 30, 2024, the outstanding amount of loans guaranteed by Mr. Eguchi was 208,916 thousand. Kazuyoshi Takahashi, the representative director of ZACC, is the guarantor for three bank loans on behalf of ZACC, which were borrowed by ZACC from two banks prior to the acquisition of ZACC. As of June 30, 2024, Mr. Takahashi's guarantee has not been released and the outstanding amount of loans guaranteed by Mr. Takahashi was 47,831 thousand. None of the borrowing agreements contain any financial covenants.
In addition, the Company entered into a 200 million yen credit facility agreement with a bank on August 7, 2023. As of December 31, 2023, the Company had used 200 million yen of the credit facility. On May 31, 2024, the Company renewed the 200 million yen credit facility agreement, which had reached its maturity date. The credit facility agreement was extended for an additional year on the same terms, with a fixed interest rate of 1.475% and a new maturity date of May 30, 2025.
The Company mainly leases commercial space for its relaxation salon from external third parties, which are either operated by the Company or a franchisee and also enters into contracts with franchisees subleasing partial spaces of leased properties under the terms and conditions that are substantially the same as the head lease contracts. As of June 30, 2024 and 2023, the Company had 238 and 237 leased salons, respectively, of which 86 and 96 salons, respectively were subleased.
There are no lease transactions classified as finance leases for the six months ended June 30, 2024 and 2023.
The table below summarizes the components of operating lease costs related to operating leases:
Thousands of Yen
Six Months Ended June 30,
2024 2023
Fixed lease cost (1) 455,243 458,069
Variable lease cost (1) 19,927 19,676
Short-term cost 11,598 23,550
Total 486,768 501,295
There are no sale-and leaseback transactions conducted in the six months ended June 30, 2024 and 2023.
Supplementary information on cash flow and other information for leasing activities for the six months ended June 30, 2024 and 2023 are as follows:
Thousands of Yen
Six Months Ended June 30,
2024 2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows 486,768 501,295
Right-of-use assets obtained in exchange for lease liabilities 271,225 459,137
Weighted average remaining lease term (in years) 3.5 3.8
Weighted average discount rate 2.02 % 2.03 %
Maturity analysis of future minimum lease payments under non-cancellable leases subsequent to June 30, 2024 are as follows:
Thousands of Yen
Year ending December 31:
2024 (remainder) 399,345
2025 657,622
2026 460,759
2027 268,606
2028 150,570
2029 and thereafter 97,381
Total 2,034,283
Less: Interest component 69,841
Present value of minimum lease payments 1,964,442
The amount of 741,511 thousand and 1,222,931 thousand of the discounted present value of minimum lease payment are included in current portion of lease liability and lease liability - net of current portion, respectively, in the condensed consolidated balance sheets.
The Company leases space from commercial facility landlords which in turn it subleases to certain franchisees of its relaxation salons. Sublease revenues are as follows for the six months ended June 30, 2024 and 2023, and included in franchise revenues:
Thousands of Yen
Six Months Ended June 30,
2024 2023
Fixed sublease income 152,367 178,733
Variable sublease income 7,037 9,224
Total 159,404 187,957
Expected future minimum lease collections to be received under non-cancellable subleases subsequent to June 30, 2024 are as follows:
Thousands of Yen
Year ending December 31:
2024 (remainder) 124,337
2025 206,660
2026 121,732
2027 49,417
2028 25,043
2029 and thereafter 21,340
Total 548,529
There are no lease transactions classified as sale-type leases and direct financing leases for the six months ended June 30, 2024 and 2023.
5. Stock-based Compensation

Frequently Asked Questions

What are the total assets of Medirom as of June 30, 2024?

Total assets of Medirom are ¥5,827,041 thousand.

How much was Medirom's net loss for the first half of 2024?

Medirom reported a net loss of ¥588,375 thousand for H1 2024.

What is the revenue from directly-operated salons for H1 2024?

Revenue from directly-operated salons was ¥3,015,663 thousand.

What was the total current liabilities for Medirom as of June 30, 2024?

Total current liabilities amounted to ¥3,300,767 thousand.

How has shareholders' equity changed by June 30, 2024?

Shareholders' equity showed a deficit of ¥364,313 thousand.

Last updated: Nov 8, 2024